COPD – FLASH Study

 If you answered yes to these questions, you may be able to take part in a new research study.   Our Research Centre in Drummoyne is participating in the study. …

CONDITION: Respiratory

GENDER: Both males and females

AGE GROUP: 18 and above

TRIAL STATUS: Closed: follow-up continuing

An Open-label, Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression

This is a Phase 3, multi centre, open label, long term (up to 52 weeks) study of the safety and efficacy of esketamine administered by nasal spray in treatment resistant depression. Study participants will …

CONDITION: Mental Health

GENDER: Both males and females

AGE GROUP: 18 and above

TRIAL STATUS: Completed

ODYSSEY – Type 2 Diabetes and High Cholesterol

We are testing the effect of an investigational drug on reducing cholesterol in patients with Type 2 Diabetes who may be at risk of developing coronary heart disease.

CONDITION: Metabolic and Endocrine

GENDER: Both males and females

AGE GROUP: 18 and above

TRIAL STATUS: Recruiting